Pluvicto, Novartis’ blockbuster radiopharmaceutical for prostate cancer, has been greenlighted by the FDA for use earlier in ...
Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.
The ouster of Peter Marks, the FDA official who oversaw vaccines, gene therapies, and the blood supply, has alarmed biopharma ...
I]t has become clear that truth and transparency are not desired by the Secretary, but rather he wishes subservient ...
Did you know men and women's heart cells prefer different kinds of fuel? Gender differences are emerging as scientists turn ...
What will be lost when medical students are no longer made to uncomfortably face death to learn from what a real human body ...
Dana, a 29-year-old nurse in St. Louis, checks her phone to see if the gig nursing app CareRev still has her scheduled at the ...
Peter Marks’ ouster comes at a time when the sector is already suffering through a years-long public markets slump.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback